Hartford Funds Management’s Merck MRK Stock Holding History

Hartford Funds Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$999K	Buy	8,304 +335	+4%	+$38.7K	0.09%	68
2025 Q4	$839K	Buy	7,969 +259	+3%	+$24.3K	0.07%	73
2025 Q3	$647K	Sell	7,710 -1,450	-16%	-$119K	0.06%	74
2025 Q2	$725K	Sell	9,160 -4,229	-32%	-$336K	0.06%	71
2025 Q1	$1.2M	Buy	13,389 +1,353	+11%	+$126K	0.11%	34
2024 Q4	$1.2M	Sell	12,036 -891	-7%	-$91.9K	0.11%	31
2024 Q3	$1.47M	Buy	12,927 +61	+0.5%	+$7.25K	0.14%	19
2024 Q2	$1.59M	Buy	12,866 +1,079	+9%	+$139K	0.15%	16
2024 Q1	$1.56M	Buy	11,787 +1,597	+16%	+$197K	0.15%	16
2023 Q4	$1.11M	Buy	10,190 +2,010	+25%	+$209K	0.11%	19
2023 Q3	$842K	Buy	8,180 +707	+9%	+$76.2K	0.09%	15
2023 Q2	$862K	Buy	7,473 +3,428	+85%	+$389K	0.09%	14
2023 Q1	$430K	Buy	4,045 +786	+24%	+$84.9K	0.04%	32
2022 Q4	$362K	Buy	+3,259	New	+$333K	0.04%	33

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hartford Funds Management's MRK Position: Q1 2026 in Review

Hartford Funds Management increased its Merck (MRK) stake by 4.2% in Q1 2026, buying an estimated $38.7K and bringing the position to 8,304 shares worth $999K. The position accounts for 0.09% of the portfolio, ranked #68.

Hartford Funds Management first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.59M in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Hartford Funds Management held 8,304 shares of Merck worth $999K as of Q1 2026.
Hartford Funds Management bought 335 Merck shares in Q1 2026, an estimated $38.7K.
Merck made up 0.09% of Hartford Funds Management's portfolio in Q1 2026, its #68 holding.
Hartford Funds Management first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
Hartford Funds Management's Merck position peaked at $1.59M in Q2 2024.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hartford Funds Management's 13F filing for Q1 2026, filed 4 May 2026.